
Here is your Pro Recap of the biggest analyst cuts you may have missed since yesterday: downgrades at Coinbase Global, Carvana, Cisco, Silk Road Medical, and WW Grainger.
InvestingPro subscribers got this news before anyone else. Start your 7-day trial to get on board.
Barclays downgraded Coinbase Global (NASDAQ:COIN) to Underweight from Equalweight with a price target of $70.00 (from $61.00). This represents the company’s third downgrade this month.
Despite the company's positive performance in revenues and costs in recent quarters, Barclays believes the current low volumes and depressed USDC market cap, coupled with regulatory uncertainties and a recent surge in share prices, leave few near-term catalysts for growth.
Shares fell more than 1% premarket today.
Carvana (NYSE:CVNA) shares fell more than 3% premarket after JPMorgan downgraded the company to Underweight from Neutral with a price target of $10.00, as reported in real time on InvestingPro.
The firm believes that the company’s valuation has disconnected from its fundamentals, noting that the recent debate on Carvana shares has centered on liquidity and its ability to navigate a potential recession and sustained weakness in the used car market, rather than focusing on long-term business model fundamentals.
Carvana saw a 9% surge in its shares yesterday, driven by a favorable inflation report and JMP Securities’ price target raise.
Cisco Systems (NASDAQ:CSCO) shares fell more than 2% yesterday after BofA Securities downgraded the company to Neutral from Buy with a price target of $56.00.
The firm expressed concern regarding the product revenue estimates for the second half of 2024 and the fiscal year 2025, suggesting that the consensus estimates appear overly optimistic.
Silk Road Medical (NASDAQ:SILK) earned two downgrades following the proposed decision by CMS, which resulted in a share price drop of more than 28% yesterday.
BofA Securities downgraded the company to Underperform from Buy with a price target of $28.00 (from $51.00), while JPMorgan downgraded to Neutral from Overweight with a price target of $28.00 (from $50.00).
WW Grainger (NYSE:GWW) shares fell more than 2%yesterday after UBS downgraded the company to Neutral from Buy with a price target of $820.00 (from $815.00).
According to the firm, it no longer perceives a low-risk opportunity for EPS upside and believes the recent re-rating has already accounted for a sustained higher level of market outgrowth.
Get ready to supercharge your investment strategy with our exclusive discounts.
Don't miss out on this limited-time opportunity to access cutting-edge tools, real-time market analysis, and expert insights. Join InvestingPro today and unlock your investing potential. Hurry, the Summer Sale won't last forever!
Begin trading today! Create an account by completing our form
At One Financial Markets we are committed to safeguarding your privacy.
Please see our Privacy Policy for details about what information is collected from you and why it is collected. We do not sell your information or use it other than as described in the Policy.
Please note that it is in our legitimate business interest to send you certain marketing emails from time to time. However, if you would prefer not to receive these you can opt-out by ticking the box below.
Alternatively, you can use the unsubscribe link at the bottom of the Demo account confirmation email or any subsequent emails we send.
By completing the form and downloading the platform you agree with the use of your personal information as detailed in the Policy.